exhibit991
基因疗法改善帕金森和萨克斯病初步胜利！Axovant两项研究获积极
AXO-Lenti-PD – Gentherapie gegen Parkinson – Gertrudis Klinik Biskirchen
exhibit991
Parkinson's Gene Therapy in Clinical Trial, AXO-Lenti-PD, Safe And Effective in Monkey Model of Disease, Study Says
AXO-Lenti-PD – Gentherapie gegen Parkinson – Gertrudis Klinik Biskirchen
Denali Therapeutics begins dosing Parkinson's patients in Phase Ib trial
Assessing Axovant Gene Therapies (OTCMKTS:SIOX) | Seeking Alpha
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
Innovative gene therapy trial for Parkinson's disease | UCL News - UCL – University College London
Document
Deck Review with Sio Gene Therapies | by Axial | Medium
AXO-Lenti-PD Gene Therapy Showing Benefits in 2nd Parkinson's Group
Injection of Lenti-TH-AADC-CH1 vector to MPTP-treated macaques improves... | Download Scientific Diagram
Axovant Announces Positive 12-month Data on AXO-Lenti-PD
Deck Review with Sio Gene Therapies - by Joshua Elkington
Potential Parkinson's Therapy, AXO-Lenti-PD, Under License by Axovant
Oxford BioMedica — Golden age for LentiVector as Axovant signs deal - Edison Group
Deck Review with Sio Gene Therapies - by Joshua Elkington
Striatal injection of Lenti-TH-AADC-CH1 reduces L-dopa–induced... | Download Scientific Diagram
Генотерапия болезни Паркинсона: это успех! | МОСМЕДПРЕПАРАТЫ
Deck Review with Sio Gene Therapies | by Axial | Medium
